Lung and heart stem cell research paves way for new COVID-19 treatments
Posted: 15 June 2023 Melbourne researchers have used heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the disease impacts different organs, paving the way for more targeted treatments. The research,…
Why this CEO thinks 454pc growth in his company is just the beginning
Posted: 15 June 2023 Telix Pharmaceuticals has topped the inaugural Financial Review Fast Global list, with international revenue growth at the Melbourne-based, cancer-fighting biotech soaring off the back of a drug approval in the US. The Fast Global…
Telix Opens European Radiopharmaceutical Production Facility
Posted: 13 June 2023 Telix today welcomes Willy Borsus, Vice-President of Wallonia, Minister of Economy, Research and Innovation, Digital, Agriculture, Urban Planning and Regional Planning to officially open Telix Manufacturing Solutions, the Company’s radiopharmaceutical production facility located in…
RMIT backs Vietnam with new $250m strategic investment fund
Posted: 13 June 2023 Today, in the presence of Australia’s Prime Minister, the Honourable Anthony Albanese MP, RMIT University announced the next phase of its Country Commitment to Vietnam, including a AUD $250 million strategic investment fund. The…
New Eye Clinical Trials Centre to Give Victorians World-First Treatments
Posted: 13 June 2023 Breakthrough Victoria is investing $10 million towards a new world-leading eye clinical trials centre that will provide Victorians with early access to new treatments aiming to prevent and cure blindness. The new eye clinical…
Clinical trials in Australia to use common voice
Posted: 9 June 2023 ARCS Australia has released a white paper to define common terms used in decentralised clinical trials providing a common and consistent language for the sector. The paper was released on day two of the…
Kinoxis awarded new US grant funding to support clinical development of KNX100 for opioid use disorder
Posted: 9 June 2023 Kinoxis Therapeutics is pleased to announce it has been awarded a UH3 grant by the National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), which is expected to…
CSIRO invests $25 million to drive biotech innovation
Posted: 9 June 2023 Australia’s national science agency, CSIRO, has invested $25 million up to 2027 in a new program that will harness the building blocks of life to solve intractable problems. Advanced Engineering Biology (AEB) is the latest…
Avecho completes development of TPM-enhanced cannabinoid gummies
Posted: 9 June 2023 Avecho Biotechnology Limited today announced it has completed the development of first generation TPM® gummies containing cannabinoids. TPM cannabinoid gummies out–perform standard products with faster onset and greater magnitude of effect.Gummies are chewable, jelly–like preparations made…
Optiscan on mission to revolutionise medical imaging
Posted: 9 June 2023 ASX-listed Optiscan Imaging is ramping up its bid to pioneer a new standard of care in digital pathology and precision surgery, with its biopsy-free, slide-free, non-invasive, live single-cell medical imaging technology. The company’s patented…
BioMelbourne Network and Wilam welcome CAI as foundational corporate partner
Posted: 8 June 2023 BioMelbourne Network’s digital transformation strategy is designed to change how our sector connects, strengthens and grows, to “reimagine engagement”. In November 2022, we launched Wilam, our Life…
Abstract & poster highlighting positive clinical results for ColoSTAT® Poster Presentation at ASCO Annual Meeting
Posted: 7 June 2023 Transformative cancer diagnostics technology company Rhythm Biosciences Ltd (ASX: RHY) (Rhythm or the Company) is pleased to announce that the abstract detailing the main results from the clinical trial for ColoSTAT®, its simple blood…
